{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:47:12Z","timestamp":1790912832083,"version":"4.1.0"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Given their immunosuppressive and anti-inflammatory properties, corticosteroids are widely used. However, corticosteroid-induced psychiatric effects are deeply concerning, since they can be severe and require accurate differential diagnosis from primary psychiatric disorders. Among corticosteroid-induced psychiatric symptoms, what kind of patients under corticosteroids develop manic and\/or psychotic symptoms and which risk factors are associated with their development remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The present systematic review aimed at giving a comprehensive overview of corticosteroids-induced symptoms of mania and\/or psychosis and at examining the clinical factors that might increase the risk of developing these adverse reactions. According to PRISMA guidelines, this systematic review included 40 papers (clinical cases = 34; quantitative research = 6).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 64.7% of clinical cases and 33.3% of research studies reviewed, patients taking corticosteroids presented with both manic and psychotic symptoms; in 11.8% of clinical cases and 1 (out of 6) quantitative research patients under corticosteroids presented with manic symptoms only, whereas in 23.5% of clinical cases and 3 quantitative studies, psychotic symptoms only. Prolonged and high-dose corticosteroid therapy, pre-existing psychiatric conditions, older age and female sex represent risk factors, which are likely to increase individual susceptibility to corticosteroid-induced symptoms of mania and\/or psychosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Although manic and psychotic symptoms often coexist in patients taking corticosteroids, the direction and nature of this relationship (e.g., which symptoms appear first, their interaction and progression over time) remain unclear. Clinicians prescribing corticosteroids might take advantage of clinimetric methods, which may allow a substantial improvement in the early detection and evaluation of severity of corticosteroid-induced manic and\/or psychotic symptoms.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1628765","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:10:13Z","timestamp":1753157413000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Corticosteroid-induced manic and\/or psychotic symptoms: a systematic review"],"prefix":"10.3389","volume":"16","author":[{"given":"Sara","family":"Gostoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Carrozzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Raimondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Subach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rafanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4456716","DOI":"10.1155\/2022\/4456716","article-title":"Mania as a rare adverse event secondary to steroid eye drops","volume":"2022","author":"Alsalem","year":"2022","journal-title":"Case Rep. Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e37627","DOI":"10.7759\/cureus.37627","article-title":"The association between prolonged use of oral corticosteroids and mental disorders: do steroids have a role in developing mental disorders?","volume":"15","author":"Alturaymi","year":"2023","journal-title":"Cureus"},{"key":"B3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.14740\/jmc3357","article-title":"Vasculitis and steroid psychosis: a case report and review of literature","volume":"10","author":"Araujo","year":"2019","journal-title":"J. Med. Cases"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e39221","DOI":"10.7759\/cureus.39221","article-title":"Corticosteroid-induced psychosis: a report of three cases","volume":"15","author":"Bachu","year":"2023","journal-title":"Cureus"},{"key":"B5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41398-019-0539-x","article-title":"Differential transcriptional response following glucocorticoid activation in cultured blood immune cells: a novel approach to PTSD biomarker development","volume":"9","author":"Breen","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1081-1206(10)62858-X","article-title":"The psychiatric side effects of corticosteroids","volume":"83","author":"Brown","year":"1999","journal-title":"Ann. Allergy. Asthma. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.12740\/PP\/28342","article-title":"Acute psychosis in the course of treatment of acute adrenal crisis with hydrocortisone in the patient with secondary adrenal insufficiency \u2013 a case study","volume":"49","author":"Brykalski","year":"2015","journal-title":"Psychiatr. Pol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000516599","article-title":"Clinimetric criteria for patient-reported outcome measures","volume":"90","author":"Carrozzino","year":"2021","journal-title":"Psychother. Psychosom."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e12594","DOI":"10.7759\/cureus.12594","article-title":"Mania induced by epidural steroid injection in an elderly female with no psychiatric history","volume":"13","author":"Chen","year":"2021","journal-title":"Cureus"},{"key":"B10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1056\/NEJM195307302490502","article-title":"Further observations on mental disturbances associated with cortisone and ACTH therapy","volume":"249","author":"Clark","year":"1953","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jpsychires.2022.09.032","article-title":"What we know about the role of corticosteroids in psychiatric disorders; evidence from animal and clinical studies","volume":"155","author":"Dabbah-Assadi","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/15622975.2024.2312572","article-title":"Corticosteroids and mania: a systematic review","volume":"25","author":"De Bock","year":"2024","journal-title":"World J. Biol. Psychiatry"},{"key":"B13","first-page":"617","article-title":"Behavioral toxicity of psychotropic drugs. I. Definition. II. Toxic effects on psychomotor functions","volume":"32","author":"DiMascio","year":"1968","journal-title":"Conn. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/bjd.15928","article-title":"Use of systemic corticosteroids for atopic dermatitis: International Eczema Council Consensus Statement","volume":"178","author":"Drucker","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.psym.2011.12.007","article-title":"The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited","volume":"53","author":"Dubovsky","year":"2012","journal-title":"Psychosomatics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e233403","DOI":"10.1136\/bcr-2019-233403","article-title":"Late-onset mania associated with corticosteroids and small cell lung carcinoma","volume":"13","author":"El Hayek","year":"2020","journal-title":"BMJ Case Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000076450","article-title":"The additional value of clinimetrics needs to be established rather than assumed","volume":"73","author":"Emmelkamp","year":"2004","journal-title":"Psychother. Psychosom."},{"key":"B18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000538526","article-title":"Clinical use of staging in psychiatry","volume":"93","author":"Fava","year":"2024","journal-title":"Psychother. Psychosom."},{"key":"B19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/JCP.0000000000000570","article-title":"Behavioral toxicity revisited: iatrogenic comorbidity in psychiatric evaluation and treatment","volume":"36","author":"Fava","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4088\/JCP.10r06444","article-title":"The clinical process in psychiatry: a clinimetric approach","volume":"73","author":"Fava","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000458458","article-title":"Clinical pharmacopsychology: conceptual foundations and emerging tasks","volume":"86","author":"Fava","year":"2017","journal-title":"Psychother. Psychosom."},{"key":"B22","first-page":"91","article-title":"Corticosteroid-Induced psychosis after a single transforaminal epidural steroid injection","volume":"118","author":"Fischer","year":"2019","journal-title":"WMJ Off. Publ. State Med. Soc. Wis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/00000542-199611000-00030","article-title":"Corticosteroid-induced mania after single regional application at the celiac plexus","volume":"85","author":"Fishman","year":"1996","journal-title":"Anesthesiology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e12792","DOI":"10.1111\/jne.12792","article-title":"Neurobehavioural complications of sleep deprivation: shedding light on the emerging role of neuroactive steroids","volume":"32","author":"Frau","year":"2020","journal-title":"J. Neuroendocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1002\/pcn5.66","article-title":"Mania after long\u2010term treatment with daily 10 mg prednisolone","volume":"1","author":"Fujii","year":"2022","journal-title":"Psychiatry Clin. Neurosci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1177\/0091217415612735","article-title":"Sustained corticosteroid-induced mania and psychosis despite cessation: a case study and brief literature review","volume":"50","author":"Gable","year":"2015","journal-title":"Int. J. Psychiatry Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"100345","DOI":"10.1016\/j.bbih.2021.100345","article-title":"Don\u2019t forget me in amidst of COVID-19 pandemic: a case series and review of literature on steroid associated psychiatric manifestations","volume":"18","author":"Grover","year":"2021","journal-title":"Brain Behav. Immun. - Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00005053-197904000-00006","article-title":"Presentation of the steroid psychoses","volume":"167","author":"Hall","year":"1979","journal-title":"J. Nerv. Ment. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"621.e1","DOI":"10.1016\/j.genhosppsych.2015.07.002","article-title":"A manic episode with psychotic features improved by methylprednisolone in a patient with multiple sclerosis","volume":"37","author":"Hotier","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e04644","DOI":"10.1002\/ccr3.4644","article-title":"Acute psychosis secondary to steroid responsive encephalopathy associated with autoimmune Hashimoto\u2019s thyroiditis","volume":"9","author":"Ibrahim","year":"2021","journal-title":"Clin. Case Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40981-018-0193-y","article-title":"A case of delirium in Tolosa-Hunt syndrome during corticosteroid therapy","volume":"4","author":"Ishikawa","year":"2018","journal-title":"JA Clin. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/08998280.2019.1629223","article-title":"Steroid-induced psychosis","volume":"32","author":"Janes","year":"2019","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e17719","DOI":"10.7759\/cureus.17719","article-title":"Corticosteroid-induced mania after previous tolerance of higher doses","volume":"13","author":"Jasani","year":"2021","journal-title":"Cureus"},{"key":"B34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4103\/0019-5545.196705","article-title":"A case of adrenoleukodystrophy presenting with manic symptoms in a patient on steroids for Addison\u2019s disease","volume":"58","author":"Jyothi","year":"2016","journal-title":"Indian J. Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.20471\/may.2021.57.01.08","article-title":"Sarcoidosis and corticosteroid therapy: dilemma from a psychiatric point of view","volume":"57","author":"Kassim","year":"2021","journal-title":"Arch. Psychiatry Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e18093","DOI":"10.7759\/cureus.18093","article-title":"Acute psychosis following corticosteroid administration","volume":"13","author":"Kazi","year":"2021","journal-title":"Cureus"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e21639","DOI":"10.1097\/MD.0000000000021639","article-title":"Anabolic steroids-induced delirium: a case report","volume":"99","author":"Khoodoruth","year":"2020","journal-title":"Med. Baltim."},{"key":"B38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s44192-024-00061-w","article-title":"Steroid-induced mania in a patient with previously well-controlled organic bipolar 1-like affective disorder secondary to acquired brain injury: case report and literature review","volume":"4","author":"King","year":"2024","journal-title":"Discov. Ment. Health"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1442","DOI":"10.1210\/clinem\/dgad701","article-title":"Neuropsychiatric adverse effects of synthetic glucocorticoids: a systematic review and meta-analysis","volume":"109","author":"Koning","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.6890\/IJGE.202210_16(4).0017","article-title":"Manic episode associated with COVID-19 and corticosteroids in a patient with prior mild cognitive impairment","volume":"16","author":"K\u00f6ro\u011flu","year":"2022","journal-title":"Int. J. Gerontol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"bcr2016217483","DOI":"10.1136\/bcr-2016-217483","article-title":"Hyperactive delirium following administration of intra-articular corticosteroid","volume":"2017","author":"Lally","year":"2017","journal-title":"BMJ Case Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"7989712","DOI":"10.1155\/2023\/7989712","article-title":"Giant cell arteritis presenting with mania, psychosis, and cognitive dysfunction: a case report","volume":"2023","author":"Latvala","year":"2023","journal-title":"Case Rep. Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e20853","DOI":"10.7759\/cureus.20853","article-title":"Four case reports of acute psychosis secondary to low doses of prednisone\/prednisolone","volume":"13","author":"Lesko","year":"2021","journal-title":"Cureus"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1016\/0165-0327(83)90022-8","article-title":"Steroid-induced psychiatric syndromes","volume":"250","author":"Lewis","year":"1983","journal-title":"JAMA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/080394801317084428","article-title":"Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia: clinical validation of a self-rating version of the UKU side effect rating scale (UKU-SERS-Pat)","volume":"55","author":"Lindstr\u00f6m","year":"2001","journal-title":"Nord. J. Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archpsyc.1981.01780290105011","article-title":"Side effects of corticosteroid therapy: Psychiatric aspects","volume":"38","author":"Ling","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e000007","DOI":"10.1136\/gpsych-2018-000007","article-title":"Switch from previous major depression comorbid with CLIPPERS to mania-like episode following glucocorticosteroid therapy: a case report","volume":"31","author":"Liu","year":"2018","journal-title":"Gen. Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/YIC.0000000000000122","article-title":"Psychiatric side effects of acute high-dose corticosteroid therapy in neurological conditions","volume":"31","author":"Lotan","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.12788\/cp.0104","article-title":"Steroid-induced psychiatric symptoms: what you need to know","volume":"20","author":"Lu","year":"2021","journal-title":"Curr. Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/medicines5030082","article-title":"Behavioral, psychiatric, and cognitive adverse events in older persons treated with glucocorticoids","volume":"5","author":"Manzo","year":"2018","journal-title":"Medicines"},{"key":"B51","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/0004867420961471","article-title":"Psychotic mania after sudden discontinuation of high-dose corticosteroids","volume":"55","author":"Martinho","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/MD.0b013e3182a72299","article-title":"Glucocorticoid therapy and the risk of infection in patients with newly diagnosed autoimmune disease","volume":"92","author":"Migita","year":"2013","journal-title":"Med. Baltim."},{"key":"B53","doi-asserted-by":"publisher","first-page":"372","DOI":"10.5152\/npa.2017.18129","article-title":"Cavum vergae, liability, and steroid treatment: manic episode, brain imaging findings, and clinical follow-up of a systemic lupus erythematosus case","volume":"54","author":"Misir","year":"2017","journal-title":"N\u00f6ro Psikiyatri Ar\u015f"},{"key":"B54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2302\/kjm.2014-0007-CR","article-title":"Steroid psychosis caused by perioperative steroid replacement for pituitary adenoma: a case report","volume":"64","author":"Mizutani","year":"2015","journal-title":"Keio J. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jad.2015.08.040","article-title":"Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses","volume":"187","author":"Morrow","year":"2015","journal-title":"J. Affect. Disord."},{"key":"B57","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/0897190013504963","article-title":"Combination of inhaled corticosteroid and bronchodilator-induced delirium in an elderly patient with lung disease","volume":"27","author":"Moss","year":"2014","journal-title":"J. Pharm. Pract."},{"key":"B58","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1192\/bjp.162.4.549","article-title":"Behavioural sensitisation and steroid-induced psychosis","volume":"162","author":"Mullen","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0306-4530(95)00031-3","article-title":"Psychopathological and neuropsychological effects of 8-days\u2019 corticosteroid treatment. A prospective study","volume":"21","author":"Naber","year":"1996","journal-title":"Psychoneuroendocrinology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e231919","DOI":"10.1136\/bcr-2019-231919","article-title":"Mania induced by isoniazid preventive therapy during steroid treatment for rheumatoid arthritis and organising pneumonia","volume":"12","author":"Nagano","year":"2019","journal-title":"BMJ Case Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/diseases12120300","article-title":"Corticosteroid-induced psychiatric disorders: mechanisms, outcomes, and clinical implications","volume":"12","author":"Nasereddin","year":"2024","journal-title":"Diseases"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1007\/s00415-014-7472-y","article-title":"New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study","volume":"261","author":"Nishimura","year":"2014","journal-title":"J. Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"B64","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2165\/00002018-200022020-00004","article-title":"Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management","volume":"22","author":"Patten","year":"2000","journal-title":"Drug Saf."},{"key":"B66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/hm.hm_17_21","article-title":"A case report: steroid-induced mania in the context of COVID-19 the compounding impact of treatment on mental health","volume":"5","author":"Perez","year":"2021","journal-title":"Heart Mind"},{"key":"B67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3390\/cells10112921","article-title":"The role of glucocorticoids in inflammatory diseases","volume":"10","author":"Reichardt","year":"2021","journal-title":"Cells"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids \u2014 new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1192\/bjp.102.429.830","article-title":"Toxic psychosis under cortisone and corticotrophin","volume":"102","author":"Ritchie","year":"1956","journal-title":"J. Ment. Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1136\/ard.59.11.926a","article-title":"Steroid psychosis after an intra-articular injection","volume":"59","author":"Robinson","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1176\/ajp.108.9.641","article-title":"The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances","volume":"108","author":"Rome","year":"1952","journal-title":"Am. J. Psychiatry"},{"key":"B73","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/1039856218758566","article-title":"Persistent mania following cessation of corticosteroids","volume":"26","author":"Roxanas","year":"2018","journal-title":"Australas. Psychiatry"},{"key":"B74","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4274\/tnd.91328","article-title":"Do steroids trigger mania in multiple sclerosis? Not always","volume":"21","author":"Sevim","year":"2015","journal-title":"T\u00fcrk N\u00f6roloi Derg."},{"key":"B75","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.autrev.2016.03.017","article-title":"Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE","volume":"15","author":"Shimizu","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3390\/biomedicines12092131","article-title":"Molecular, pathophysiological, and clinical aspects of corticosteroid-induced neuropsychiatric effects: from bench to bedside","volume":"12","author":"Sof\u00eda-Avenda\u00f1o-Lopez","year":"2024","journal-title":"Biomedicines"},{"key":"B77","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.abd.2023.05.005","article-title":"Side effects of chronic systemic glucocorticoid therapy: what dermatologists should know","volume":"99","author":"Tavares","year":"2024","journal-title":"An. Bras. Dermatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00406-019-01049-2","article-title":"Corticosteroid-induced psychiatric disorders: genetic studies are needed","volume":"269","author":"Thibaut","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/00004583-199708000-00006","article-title":"Medication-induced psychotic reaction","volume":"36","author":"T\u00fcrkta\u015f","year":"1997","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"B80","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1176\/appi.psy.42.6.461","article-title":"Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures","volume":"42","author":"Wada","year":"2001","journal-title":"Psychosomatics"},{"key":"B81","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/pnp.441","article-title":"Corticosteroid-induced psychosis in rheumatoid arthritis: corticosteroid-Induced psychosis","volume":"20","author":"Ward","year":"2016","journal-title":"Prog. Neurol. Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4187\/respcare.06314","article-title":"Clinical pharmacology of corticosteroids","volume":"63","author":"Williams","year":"2018","journal-title":"Respir. Care"},{"key":"B83","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00131746-200603000-00002","article-title":"Self-rated global measure of the frequency, intensity, and burden of side effects","volume":"12","author":"Wisniewski","year":"2006","journal-title":"J. Psychiatr. Pract."},{"key":"B84","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/npr2.12204","article-title":"Oral corticosteroid dosage and clinical presentation of psychiatric conditions after steroid use: a consultation\u2010liaison psychiatry service\u2019s experience","volume":"41","author":"Yagi","year":"2021","journal-title":"Neuropsychopharmacol. Rep."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1628765\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:10:15Z","timestamp":1753157415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1628765\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":84,"alternative-id":["10.3389\/fphar.2025.1628765"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1628765","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"article-number":"1628765"}}